MoneyWorks4Me

Sun Pharmaceutical Industries informs about press release

15 Jul 2026 Evaluate

Sun Pharmaceutical Industries has informed that it enclosed a copy of the press release titled ‘Sun Pharma receives approval to manufacture and market generic semaglutide in South Africa,’ which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..